A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)

"All doses of BMN053 will be administered as IV infusions. The proposed doses are as follows:~• 3 mg/kg"

"All doses of BMN053 will be administered as IV infusions. The proposed doses are as follows:~• 4-6 mg/kg"

All doses of PRO053 will be administered as IV infusions. The proposed doses will be decided upon completion of the Regimen Selection Phase of Groups 2 and 3

All doses of BMN053 have been administered as subcutaneous injections.

All doses of PRO053 will be administered as IV infusions. The proposed doses will be decided upon completion of the Regimen Selection Phase of Groups 2 and 3 and the Treatment Phase Group 4.